Augmont Enterprises Reports Nil Deviation in Utilization of ₹620 Crore IPO Proceeds
Augmont Enterprises Ltd · Others (Uncategorized) · 05 Nov 2026, 3:06 am
Augmont Enterprises Reports Nil Deviation in Utilization of ₹620 Crore IPO Proceeds Augmont Enterprises reported nil deviation in the utilization of ₹620.00 crore raised via its public issue on 27th Aug'26, as per its statement for the quarter ended 30th Sep'26. The company deployed ₹465.23 crore toward working capital and inventory scaling requirements against an original allocation of ₹465.00 crore, and ₹107.76 crore toward general corporate purposes. Offer expenses accounted for ₹0.41 crore utilized out of an allocated ₹47.24 crore. The statement was reviewed by CARE Ratings Limited and approved by the Audit Committee on 4th Nov'26.
Original exchange filing (PDF)
More announcements from Augmont Enterprises Ltd
- Transcript of Earnings Conference Call with respect to Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. · 11 Nov 2026
- Monitoring Agency Report for the quarter ended 30th September 2026- in relation to the Public Issue of Augmont Enterprises Limited ("the Company"). · 06 Nov 2026
- Audio Recording of virtual Earnings Conference Call with respect to Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. · 06 Nov 2026
- Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find .... · 05 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), as amended from time to time, please find enclosed herewith, .... · 05 Nov 2026
- Augmont Enterprises Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- Approval of Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September 2026. · 05 Nov 2026
- Outcome of the Board Meeting held on 04th November 2026. · 05 Nov 2026
